Form4insider filings, from the source

SEC Form 4 · accession 0001645627-17-000111

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Aug 23, 2017
Accepted (ET)
Aug 25, 2017 · 8:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockAug 23, 2017P3,000$0.0241A22,647,889D
Common StockAug 24, 2017P3,000$0.0243A22,640,889D
Common StockAug 24, 2017P10,000$0.0229A22,650,889D
Common StockAug 24, 2017P3,000$0.023A22,653,889D
Common StockAug 24, 2017P5,000$0.0229A22,658,889D
Common StockAug 24, 2017P5,000$0.0229A22,663,889D
Common StockAug 24, 2017P5,000$0.0225A22,668,889D
Common StockAug 24, 2017P3,000$0.0225A22,671,889D
Common StockAug 24, 2017P3,000$0.0224A22,674,889D
Common StockAug 24, 2017P5,000$0.0224A22,679,889D
Common StockAug 24, 2017P3,000$0.0224A22,682,889D
Common StockAug 24, 2017P5,000$0.023A22,687,889D
Common StockAug 24, 2017P5,000$0.0237A22,692,889D
Common StockAug 24, 2017P5,000$0.0238A22,697,889D
Common StockAug 24, 2017P1,000$0.0238A22,698,889D
Common StockAug 24, 2017P5,000$0.0238A22,703,889D
Common StockAug 24, 2017P5,000$0.0238A22,708,889D
Common StockAug 24, 2017P3,000$0.0236A22,711,889D
Common StockAug 24, 2017P5,000$0.0238A22,716,889D
Common StockAug 24, 2017P3,000$0.0238A22,719,889D
Common StockAug 24, 2017P3,000$0.0234A22,722,889D
Common StockAug 24, 2017P3,000$0.0235A22,725,889D

Table II — derivative securities

No Table II lines on this filing.